Brimble Margaret A, Davey Roger M, McLeod Malcolm D, Murphy Maureen
Department of Chemistry, University of Auckland, 23 Symonds St., Auckland, New Zealand.
Org Biomol Chem. 2003 May 21;1(10):1690-700. doi: 10.1039/b301449p.
The synthesis of an isomeric mixture of 4-O-acetyl-3-azido-2,3,6-trideoxy-beta-D-arabino-hexopyranosyl analogues 6 of the C-glycosylpyranonaphthoquinone antibiotic medermycin is described. The key 3-acetyl-6-(4-O-acetyl-3-azido-2,3,6-trideoxy-beta-D-arabino- hexopyranosyl)-5-methoxy-1,4-naphthoquinone 8 was prepared via Stille coupling of 6-(3-azido-2,3,6-trideoxy-beta-D-arabino-hexopyranosyl)-3-bromo-1,4- naphthoquinone 17 with (alpha-ethoxyvinyl)tributyl-stannane followed by hydrolysis and oxidation of the resultant hydroquinone 18. Bromonaphthoquinone 17 in turn was afforded by oxidative demethylation of 6-(4-O-acetyl-3-azido-2,3,6-trideoxy-beta-D-arabino-hexopyranosyl)-3- bromo-1,4,5-trimethoxynaphthalene 16 formed by regioselective bromination of 6-(4-acetyl-3-azido-2,3,6-trideoxy- beta-D-arabino-hexopyranosyl)-1,4,5-trimethoxynaphthalene 10. This latter naphthalene 10 was prepared via direct C-glycosylation of naphthol 12 with glycosyl donor 11 using BF3.Et2O in acetonitrile. The regioselectivity of the bromination of naphthalene 10 was independently determined by reductive monomethylation of the 6-(4-O-acetyl-3-azido-2,3,6-trideoxy-beta-D-arabino- hexopyranosyl)-5-methoxy-1,4-naphthoquinone 22 to naphthol 23 followed by selective ortho bromination to bromide 24 and methylation to 16. Attempts to effect acetylation of 6-(4-O-acetyl-3-azido-2,3,6-trideoxy-beta-D-arabino- hexopyranosyl)-3-bromo-1,4,5-trimethoxynaphthalene 16 and 3-bromo-6-(3-dimethylamino-2,3,6-trideoxy-beta-D-arabino- hexopyranosyl)-1,4,5-trimethoxynaphthalene 26 via Stille coupling with (alpha-ethoxyvinyl)tributylstannane were low yielding thereby establishing the necessity to use an azido group as a latent dimethylamino group and a more electrophilic bromonaphthoquinone as the coupling partner for the Stille reaction. Addition of 2-trimethylsilyloxyfuran 9 to 3-acetyl-6-(4-O-acetyl-3-azido-2,3,6-trideoxy-beta-D-arabino-hexopyranosyl)- 5-methoxy-1,4-naphthoquinone 8 afforded the furofuran adducts 7 and 19 as an inseparable mixture of diastereomers. Oxidative rearrangement of this diastereomeric mixture using ceric ammonium nitrate afforded the inseparable diastereomeric furonaphthopyrans 6 and 20.
描述了C-糖基吡喃萘醌抗生素美登霉素的4-O-乙酰基-3-叠氮基-2,3,6-三脱氧-β-D-阿拉伯己吡喃糖基类似物6的异构体混合物的合成。关键的3-乙酰基-6-(4-O-乙酰基-3-叠氮基-2,3,6-三脱氧-β-D-阿拉伯己吡喃糖基)-5-甲氧基-1,4-萘醌8是通过6-(3-叠氮基-2,3,6-三脱氧-β-D-阿拉伯己吡喃糖基)-3-溴-1,4-萘醌17与(α-乙氧基乙烯基)三丁基锡进行Stille偶联,然后将所得的对苯二酚18水解和氧化而制备的。溴代萘醌17又是由6-(4-O-乙酰基-3-叠氮基-2,3,6-三脱氧-β-D-阿拉伯己吡喃糖基)-3-溴-1,4,5-三甲氧基萘16氧化脱甲基得到的,16是通过对6-(4-乙酰基-3-叠氮基-2,3,6-三脱氧-β-D-阿拉伯己吡喃糖基)-1,4,5-三甲氧基萘10进行区域选择性溴化而形成的。后者的萘10是通过在乙腈中使用BF3·Et2O使萘酚12与糖基供体11直接进行C-糖基化反应制备的。萘10溴化反应的区域选择性是通过将6-(4-O-乙酰基-3-叠氮基-2,3,6-三脱氧-β-D-阿拉伯己吡喃糖基)-5-甲氧基-1,4-萘醌22还原单甲基化得到萘酚23,然后进行选择性邻位溴化得到溴化物24,再甲基化得到16来独立确定的。尝试通过与(α-乙氧基乙烯基)三丁基锡进行Stille偶联来实现6-(4-O-乙酰基-3-叠氮基-2,3,6-三脱氧-β-D-阿拉伯己吡喃糖基)-3-溴-1,4,5-三甲氧基萘16和3-溴-6-(3-二甲基氨基-2,3,6-三脱氧-β-D-阿拉伯己吡喃糖基)-1,4,5-三甲氧基萘26的乙酰化反应,产率较低,从而确定了有必要使用叠氮基作为潜在的二甲基氨基,并使用更具亲电性的溴代萘醌作为Stille反应的偶联伙伴。将2-三甲基硅氧基呋喃9加到3-乙酰基-6-(4-O-乙酰基-3-叠氮基-2,3,6-三脱氧-β-D-阿拉伯己吡喃糖基)-5-甲氧基-1,4-萘醌8上,得到呋喃并呋喃加合物7和19,它们是不可分离的非对映异构体混合物。使用硝酸铈铵对该非对映异构体混合物进行氧化重排,得到不可分离的非对映异构体呋喃萘并吡喃6和20。